Chong-yang Deng

发表

Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model

Yuquan Wei, Xia Zhao, Cheng Peng, 2011, PloS one.

A Novel Small Molecule, (E)-5-(2,4-di-tert-butyl-6-((2,4-dioxothiazolidin-5-ylidene)methyl)phenyl)-5′-methyl-7,7′-dimethoxy-4,4′-bibenzo[d][1,3]dioxole-5,5′-dicarboxylate (7k), Alleviates the Development of d-Galactosamine/Lipopolysaccharide-Induced Acute Liver Failure by Inhibiting Macrophage Infil

Liang Ma, Guangcheng Wang, Li-juan Chen, 2012, Journal of Pharmacology and Experimental Therapeutics.

A Novel Small Molecule, (E)-5-(2,4-di-tert-butyl-6-((2,4- dioxothiazolidin-5-ylidene)methyl)phenyl)-5 -methyl-7,7-dimethoxy-4,4 -bibenzo[d][1,3]dioxole-5,5 -dicarboxylate (7k), Alleviates the Development of D-Galactosamine/ Lipopolysaccharide-Induced Acute Liver Failure by Inhibiting Macrophage Infi

Guangcheng Wang, Xuewei Wang, Chong-yang Deng, 2012 .

(Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione protects rats from carbon tetrachloride-induced liver injury and fibrogenesis.

Yuquan Wei, Liang Ma, Hao Zheng, 2012, World journal of gastroenterology.

A Novel Small Molecule, ( E )-5-(2,4-di-tert-butyl-6-((2,4-dioxothiazolidin-5-ylidene)methyl)phenyl)-5 -dimethoxy-4,4 d (cid:1) -dicarboxylate ( 7k ), Alleviates the Development of D -Galactosamine/ Lipopolysaccharide-Induced Acute Liver Failure by Inhibiting Macrophage Infiltration and Regulating C

Guangcheng Wang, Xuewei Wang, Chong-yang Deng, 2012 .

Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.

Yuquan Wei, Xia Zhao, Lulu Cai, 2011, Journal of pharmaceutical sciences.

Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol.

Yuquan Wei, Xia Zhao, Jiaolin Wen, 2011, International journal of pharmaceutics.

Rational design, synthesis, and pharmacological properties of pyranochalcone derivatives as potent anti-inflammatory agents.

Yuquan Wei, X. Liang, Mingli Xiang, 2012, European journal of medicinal chemistry.

Synthesis and biological evaluation of novel dimethyl[1,1'-biphenyl]-2,2'-dicarboxylate derivatives containing thiazolidine-2,4-dione for the treatment of concanavalin A-induced acute liver injury of BALB/c mice.

Yuquan Wei, Tao Chen, Liang Ma, 2011, European journal of medicinal chemistry.

Discovery of a Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor (HSK0935) for the Treatment of Type 2 Diabetes.

Suxin Zheng, Chong-yang Deng, Lei Chen, 2017, Journal of medicinal chemistry.

A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance.

Mingli Xiang, Liang Ma, Li-juan Chen, 2011, European journal of pharmacology.

(Z)2‐(5‐(4‐methoxybenzylidene)‐2, 4‐dioxothiazolidin‐3‐yl) acetic acid protects rats from CCl4‐induced liver injury

Hao Zheng, Chong-yang Deng, Li-Juan Chen, 2012, Journal of gastroenterology and hepatology.

Synthesis and Evaluation of 5‐Benzylidenethiazolidine‐2,4‐dione Derivatives for the Treatment of Non‐Alcoholic Fatty Liver Disease

X. Liang, Liang Ma, Jinying Chen, 2012, Archiv der Pharmazie.